Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Bill Gropp, NCSA Director Fellowship awardee Ray Xu was a SPIN intern in 2023-24 and worked on a project titled, “Understanding reading development: behavioral and computational approaches.” ...

The two astronauts have a busy day ahead of them. Hague and Williams will "patch light leaks in the NICER X-ray telescope, then ready the Alpha Magnetic Spectrometer for future upgrades," NASA ...

Watching content on a Blu-ray player is still one of the best way to enjoy your favorites, and if you're the type of person who has a big disc library or likes the idea of actually owning the ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

Xu Jiajin, who killed eight and injured 17 on a campus in Wuxi, Jiangsu province, in November, was executed on Monday after China's top court had approved his death sentence. The execution was ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.